Paradoxically, MYC mRNA expression is also elevated in the WNT MBs group, to a similar level as in Group 3 MBs, which indicates that MYC expression – in contrast to MYC amplification – is not a reliable prognostic factor in MB patients [12]. This evidence concerns the gene MYC and Mobius syndrome.